For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...

The IAEA is launching a year-long coordinated research project to develop computed tomography-based guidelines on prostate cancer contouring — a critical step in the cancer treatment process that ...

A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in ...

NEW YORK, NY / ACCESS Newswire / December 12, 2025 / Industries rarely adopt new technology in a straight line. The process unfolds in stages that are predictable to insiders but invisible to the ...

John Eimen, a former child star known for his guest spot in "Leave it to Beaver," died Friday, Nov. 21, a representative confirmed. He was 76. Eimen died at his home in Mukilteo, Washington, from ...

When "Dilbert" creator Scott Adams recently made a public plea for help accessing a life-extending cancer treatment, the story drew national attention — and sparked some questions about the drug ...

Elon Musk is back on his rambling about the Tesla Roadster being able to “fly” and claims a demo is coming by the end of the year. But we’ve heard it before… Tesla CEO Elon Musk went on Joe Rogan’s ...

Approaches to early detection of cancer often seem contentious, but the big-picture view is actually one of remarkable consensus. All major guideline groups recommend the Papanicolaou smear, ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer. Adding the drug enzalutamide to standard hormone therapy reduced the risk of ...

People with diabetes may experience changes in their urinary and digestive health, and research shows there may be different effects on the body impacting the development of prostate cancer. Diabetes ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay disease progression in men with specific DNA repair gene mutations. In the ...